This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1989 Mar 16;320(11):709-18.

doi: 10.1056/NEJM198903163201107.

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris

M Packer¹

Affiliations

PMID: 2564164
DOI: 10.1056/NEJM198903163201107

Review

Drug therapy. Combined beta-adrenergic and calcium-entry blockade in angina pectoris

M Packer. N Engl J Med. 1989.

. 1989 Mar 16;320(11):709-18.

doi: 10.1056/NEJM198903163201107.

Author

M Packer¹

Affiliation

¹ Department of Medicine, Mount Sinai School of Medicine, New York.

PMID: 2564164
DOI: 10.1056/NEJM198903163201107

No abstract available

PubMed Disclaimer

Similar articles

[Beta blockers in stable angina pectoris].
Fluri M, Meier B. Fluri M, et al. Praxis (Bern 1994). 1995 Mar 7;84(10):288-95. Praxis (Bern 1994). 1995. PMID: 7892549 Review. German.
Management of unstable angina pectoris with maximal medical treatment (combination of intravenous nitrates, beta-blockers, calcium antagonists and heparin).
Thieuleux FA, Vilarem D, Lablanche JM, Asseman PA, Thery C, Bertrand ME. Thieuleux FA, et al. Bibl Cardiol. 1985;(39):88-96. Bibl Cardiol. 1985. PMID: 2877656 No abstract available.
Treatment of stable angina pectoris with calcium antagonists alone or combined with beta-blocking agents: a review of the literature.
Bélanger LG, Charbonneau M, Lavallée JP, Lenis J, Ouellet AC. Bélanger LG, et al. Can J Cardiol. 1986 Jul-Aug;2(4):212-7. Can J Cardiol. 1986. PMID: 2876764 Review.
Stable angina: maximal medical therapy is not the same as optimal medical therapy.
Jackson G. Jackson G. Int J Clin Pract. 2000 Jul-Aug;54(6):351. Int J Clin Pract. 2000. PMID: 11092105 No abstract available.
[Clinical pharmacology and indications for treatment with calcium antagonists].
Bölter C. Bölter C. Z Arztl Fortbild (Jena). 1984;78(1):1-4. Z Arztl Fortbild (Jena). 1984. PMID: 6143456 Review. German. No abstract available.

See all similar articles

Cited by

Electrophysiologic effects of amlodipine vs. diltiazem in patients with coronary artery disease and beta-blocking therapy.
Santarelli P, Biscione F, Natale A, Manzoli A, Lanza GA. Santarelli P, et al. Cardiovasc Drugs Ther. 1994 Aug;8(4):653-8. doi: 10.1007/BF00877419. Cardiovasc Drugs Ther. 1994. PMID: 7848900 Clinical Trial.
Therapeutic options in treating acute myocardial infarction.
Danforth JW. Danforth JW. West J Med. 1989 Oct;151(4):440-7. West J Med. 1989. PMID: 2531500 Free PMC article. Review.
Influence of nicardipine on the pharmacokinetics and pharmacodynamics of propranolol in healthy volunteers.
Schoors DF, Vercruysse I, Musch G, Massart DL, Dupont AG. Schoors DF, et al. Br J Clin Pharmacol. 1990 May;29(5):497-501. doi: 10.1111/j.1365-2125.1990.tb03671.x. Br J Clin Pharmacol. 1990. PMID: 2350528 Free PMC article. Clinical Trial.
Secondary prevention with calcium antagonists after acute myocardial infarction.
Hansen JF. Hansen JF. Drugs. 1992;44 Suppl 1:33-43. doi: 10.2165/00003495-199200441-00007. Drugs. 1992. PMID: 1283582 Clinical Trial.
Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation.
Stanley WC, Sabbah HN. Stanley WC, et al. Heart Fail Rev. 2005 Dec;10(4):275-9. doi: 10.1007/s10741-005-7542-4. Heart Fail Rev. 2005. PMID: 16583175 Review. No abstract available.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

K04-HL01229/HL/NHLBI NIH HHS/United States

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information